Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools.
作者信息
El Jurdi Najla, Waldman Meryl A, Schulz Eduard, Mina Alain, Li Grace, Carpenter Ashley, Theis Jason D, Sethi Sanjeev, Caza Tiffany, Seshan Surya V, Pavletic Steven Z
机构信息
Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20232.
Abstract
摘要
相似文献
1
Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools.
Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20232.
2
The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease.
Nephrol Dial Transplant. 2011 Jun;26(6):2025-31. doi: 10.1093/ndt/gfq645. Epub 2010 Oct 20.
3
Membranous nephropathy as a manifestation of graft-versus-host disease: association with HLA antigen typing, phospholipase A2 receptor, and C4d.
Am J Kidney Dis. 2014 Dec;64(6):987-93. doi: 10.1053/j.ajkd.2014.09.001. Epub 2014 Oct 8.
4
Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation - a case series and literature review.
BMC Nephrol. 2024 Aug 8;25(1):254. doi: 10.1186/s12882-024-03675-y.
5
A case of membranous nephropathy as a manifestation of graft-versus-host disease.
Kidney Res Clin Pract. 2013 Mar;32(1):39-42. doi: 10.1016/j.krcp.2012.09.008. Epub 2012 Oct 15.
6
De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy.
Exp Clin Transplant. 2013 Feb;11(1):75-8. doi: 10.6002/ect.2012.0078. Epub 2012 Jul 18.
7
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Cochrane Database Syst Rev. 2024 Nov 7;11(11):CD010189. doi: 10.1002/14651858.CD010189.pub3.
8
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Nephrol Dial Transplant. 2007 May;22(5):1369-76. doi: 10.1093/ndt/gfl795. Epub 2007 Jan 25.
9
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Brain. 2010 Oct;133(10):2852-65. doi: 10.1093/brain/awq245. Epub 2010 Sep 15.
10
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Cochrane Database Syst Rev. 2012 Sep 12(9):CD009159. doi: 10.1002/14651858.CD009159.pub2.
本文引用的文献
1
FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection.
Kidney Int. 2024 Nov;106(5):985-990. doi: 10.1016/j.kint.2024.08.009. Epub 2024 Aug 23.
2
Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation - a case series and literature review.
BMC Nephrol. 2024 Aug 8;25(1):254. doi: 10.1186/s12882-024-03675-y.
3
Clinical characteristics of membranous nephropathy after allogeneic hematopoietic stem cell transplantation: A real-world multicenter study.
Ann Hematol. 2024 Oct;103(10):4261-4270. doi: 10.1007/s00277-024-05875-w. Epub 2024 Jul 11.
4
Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.
Transplant Cell Ther. 2023 Dec;29(12):772.e1-772.e10. doi: 10.1016/j.jtct.2023.09.016. Epub 2023 Sep 28.
5
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms.
Clin Kidney J. 2023 Feb 6;16(6):896-900. doi: 10.1093/ckj/sfad023. eCollection 2023 Jun.
6
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
Transplant Cell Ther. 2022 Aug;28(8):426-445. doi: 10.1016/j.jtct.2022.05.038. Epub 2022 May 31.
7
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1.
J Am Soc Nephrol. 2022 May;33(5):1033-1044. doi: 10.1681/ASN.2021111488. Epub 2022 Mar 23.
8
NELL1-Associated Membranous Glomerulopathy After Hematopoietic Stem Cell Transplantation.
Kidney Int Rep. 2021 May 4;6(7):1992-1995. doi: 10.1016/j.ekir.2021.04.033. eCollection 2021 Jul.
9
Role of FAT1 in health and disease.
Oncol Lett. 2021 May;21(5):398. doi: 10.3892/ol.2021.12659. Epub 2021 Mar 18.
10
New 'Antigens' in Membranous Nephropathy.
J Am Soc Nephrol. 2021 Feb;32(2):268-278. doi: 10.1681/ASN.2020071082. Epub 2020 Dec 30.
Zotero 插件